{
    "SPADE_N_03181": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_03181",
            "Peptide Name": "Human lactoferricin (LfcinH; one chain of Lactotransferrin; Human, mammals, animals)",
            "Source": "Homo sapiens (Human)",
            "Family": "Belongs to the transferrin family",
            "Gene": "LTF",
            "Sequence": "GRRRSVQWCAVSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCIQA",
            "Sequence Length": 48,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P02788",
                "http://www.uniprot.org/uniprot/B7Z4X2",
                "http://www.uniprot.org/uniprot/E7EQH5",
                "http://www.uniprot.org/uniprot/O00756",
                "http://www.uniprot.org/uniprot/Q16780",
                "http://www.uniprot.org/uniprot/Q16785",
                "http://www.uniprot.org/uniprot/Q16786",
                "http://www.uniprot.org/uniprot/Q16789",
                "http://www.uniprot.org/uniprot/Q8IU92"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram-"
            ],
            "Target Organism": "Gram-negative bacterium:Escherichia coli serotype O111.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "Not included yet",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not included yet",
            "N-terminal Modification": "Not included yet",
            "C-terminal Modification": "Not included yet",
            "Stereochemistry": "Not included yet",
            "Structure Description": "LfcinH shows a helical content from Gln14 to Lys29 in the membrane mimetic solvent but a nonexistent beta-sheet character in either the N- or C-terminal regions of the peptide. The LfcinH structure determined in aqueous solution displays a nascent helix in the form of a coiled conformation in the region from Gln14 to Lys29.",
            "Formula": "C238H391N81O65S5",
            "Mass": 5587.48,
            "PI": 10.83,
            "Net Charge": 8,
            "Hydrophobicity": -0.78,
            "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Lactoferricin binds to the bacterial surface and is crucial for the bactericidal functions. Has some antiviral activity against papillomavirus infection. N-terminal region shows strong antifungal activity against C.albicans. Contains two BBXB heparin-binding consensus sequences that appear to form the predominate functional GAG-binding site.",
            "Tissue specificity": "High levels are found in saliva and tears, intermediate levels in serum and plasma, and low levels in urine.",
            "Literature": [
                {
                    "Title": "Structure and association of human lactoferrin peptides with Escherichia coli lipopolysaccharide.",
                    "Pubmed ID": "15155221",
                    "Reference": "Antimicrob Agents Chemother. 2004 Jun;48(6)2190-2198.",
                    "Author": "Chapple DS, Hussain R, Joannou CL, Hancock RE, Odell E, Evans RW, Siligardi G.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15155221"
                },
                {
                    "Title": "Human lactoferricin is partially folded in aqueous solution and is better stabilized in a membrane mimetic solvent.",
                    "Pubmed ID": "16048952",
                    "Reference": "Antimicrob Agents Chemother. 2005 Aug;49(8)3387-3395.",
                    "Author": "Hunter HN, Demcoe AR, Jenssen H, Gutteberg TJ, Vogel HJ.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16048952"
                }
            ],
            "Frequent Amino Acids": "RQC",
            "Absent Amino Acids": "HLOUY",
            "Basic Residues": 10,
            "Acidic Residues": 2,
            "Hydrophobic Residues": 18,
            "Polar Residues": 33,
            "Positive Residues": 10,
            "Negative Residues": 2,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_01568",
                    "Similarity": 1.0,
                    "Sequence": "VSQPEATKCFQWQRNMRKVRGPPVSCIKRDSPIQCI"
                },
                {
                    "SPADE_ID": "SPADE_N_08743",
                    "Similarity": 1.0,
                    "Sequence": "EATKCFQWQRNMRKVRGPPVSCIKR"
                },
                {
                    "SPADE_ID": "SPADE_UN_21545",
                    "Similarity": 1.0,
                    "Sequence": "EATKCFQWQRNMRKVRGPPVSCIKR"
                }
            ]
        }
    }
}